{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:38:07Z","timestamp":1760647087624},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Hidradenitis suppurativa is a chronic skin condition characterized by recurrent painful abscesses usually limited to the intertriginous areas. Global prevalence has been estimated at up to 4% of the population. The exact pathogenesis of hidradenitis suppurativa is yet to be elucidated; however, recent research has shown that the disease occurs under the influence of multiple genetic, environmental, and lifestyle factors. Repeated insults result in sinus tract formation and disfigurement, which can have a significant psychosocial effect on patients. A wide range of treatments are available but none are curative. A combination antibiotic regimen is considered first line, and research into the use of biologics has been promising. Early recognition and treatment is paramount to achieving a better prognosis and improving patient quality of life.<\/jats:p>","DOI":"10.1097\/01.jaa.0000578768.62051.13","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T19:57:26Z","timestamp":1570564646000},"page":"36-42","source":"Crossref","is-referenced-by-count":8,"title":["Recognition, diagnosis, and treatment of hidradenitis suppurativa"],"prefix":"10.1097","volume":"32","author":[{"given":"Caitlyn","family":"Duran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Baumeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"4","key":"R1-20230817","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anplas.2017.03.012","article-title":"Non-surgical treatments for hidradenitis suppurativa: a systematic review","volume":"62","author":"Robert","year":"2017","journal-title":"Ann Chir Plast Esthet"},{"issue":"7","key":"R2-20230817","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-4632.2004.02536.x","article-title":"\u201cHidradenitis suppurativa\u201d is acne inversa! An appeal to (finally) abandon a misnomer","volume":"44","author":"Sellheyer","year":"2005","journal-title":"Int J Dermatol"},{"issue":"4","key":"R3-20230817","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","article-title":"Hidradenitis suppurativa: a comprehensive review","volume":"60","author":"Alikhan","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"R4-20230817","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","article-title":"Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis","volume":"77","author":"Garg","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"R5-20230817","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00011-017-1074-y","article-title":"The critical role of macrophages in the pathogenesis of hidradenitis suppurativa","volume":"66","author":"Shah","year":"2017","journal-title":"Inflamm Res"},{"issue":"1","key":"R6-20230817","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2229-5178.105454","article-title":"Acne inversa (hidradenitis suppurativa): a review with a focus on pathogenesis and treatment","volume":"4","author":"Wollina","year":"2013","journal-title":"Indian Dermatol Online J"},{"issue":"11","key":"R7-20230817","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00268-017-4091-7","article-title":"35-year experience with surgical treatment of hidradenitis suppurativa","volume":"41","author":"Burney","year":"2017","journal-title":"World J Surg"},{"issue":"2","key":"R8-20230817","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2340\/00015555-2129","article-title":"Disutility in patients with hidradenitis suppurativa: a cross-sectional study using EuroQoL-5D","volume":"96","author":"Riis","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"R9-20230817","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.det.2015.07.003","article-title":"The handicap of hidradenitis suppurativa","volume":"34","author":"Deckers","year":"2016","journal-title":"Dermatol Clin"},{"issue":"4","key":"R10-20230817","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"R11-20230817","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"6","key":"R12-20230817","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/exd.13211","article-title":"Should hidradenitis suppurativa\/acne inversa best be renamed as \u201cdissecting terminal hair folliculitis\u201d","volume":"26","author":"Chen","year":"2017","journal-title":"Exp Dermatol"},{"issue":"2","key":"R13-20230817","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2133.2010.10034.x","article-title":"Hidradenitis suppurativa\/acne inversa: bilocated epithelial hyperplasia with very different sequelae","volume":"164","author":"von Laffert","year":"2011","journal-title":"Br J Dermatol"},{"issue":"5","key":"R14-20230817","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjd.12233","article-title":"Preliminary findings suggest hidradenitis suppurativa may be due to defective follicular support","volume":"168","author":"Danby","year":"2013","journal-title":"Br J Dermatol"},{"issue":"2","key":"R15-20230817","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cid\/cix285","article-title":"The microbiological landscape of anaerobic infections in hidradenitis suppurativa: a prospective metagenomic study","volume":"65","author":"Guet-Revillet","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"10","key":"R16-20230817","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/exd.12793","article-title":"The bacteriology of hidradenitis suppurativa: a systematic review","volume":"24","author":"Ring","year":"2015","journal-title":"Exp Dermatol"},{"issue":"2","key":"R17-20230817","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2340\/00015555-2503","article-title":"Normal skin microbiota is altered in pre-clinical hidradenitis suppurativa","volume":"97","author":"Ring","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"1\u20133","key":"R18-20230817","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2011.08.047","article-title":"Pathogenesis and pharmacotherapy of Hidradenitis suppurativa","volume":"672","author":"Nazary","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"R19-20230817","first-page":"44","article-title":"Finasteride in hidradenitis suppurativa: a \u201cmale\u201d therapy for a predominantly \u201cfemale\u201d disease","volume":"9","author":"Khandalavala","year":"2016","journal-title":"J Clin Aesthet Dermatol"},{"issue":"2","key":"R20-20230817","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"R21-20230817","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1468-3083.2000.00087.x","article-title":"The natural history of hidradenitis suppurativa","volume":"14","author":"von der Werth","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"R22-20230817","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/ced.13025","article-title":"Prodromal symptoms in hidradenitis suppurativa","volume":"42","author":"Ring","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"R23-20230817","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2450401","article-title":"The clinical significance of increased serum proinflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with hidradenitis suppurativa","volume":"2017","author":"Jim\u00e9nez-Gallo","year":"2017","journal-title":"Mediators Inflamm"},{"issue":"1","key":"R24-20230817","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/derm.2.1.12490","article-title":"Comorbidities of hidradenitis suppurativa (acne inversa)","volume":"2","author":"Fimmel","year":"2010","journal-title":"Dermatoendocrinol"},{"issue":"3","key":"R25-20230817","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2340\/00015555-2513","article-title":"Hurley staging refined: a proposal by the Dutch hidradenitis suppurativa expert group","volume":"97","author":"Horv\u00e1th","year":"2017","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"R26-20230817","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2133.2009.09198.x","article-title":"Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity","volume":"161","author":"Sartorius","year":"2009","journal-title":"Br J Dermatol"},{"issue":"2","key":"R27-20230817","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jdermsci.2016.08.010","article-title":"Combination of oral zinc gluconate and topical triclosan: an anti-inflammatory treatment modality for initial hidradenitis suppurativa","volume":"84","author":"Hessam","year":"2016","journal-title":"J Dermatol Sci"},{"issue":"2","key":"R28-20230817","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2133.2011.10339.x","article-title":"A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa","volume":"165","author":"Miller","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"R29-20230817","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/ijd.13798","article-title":"Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy","volume":"57","author":"Shanmugam","year":"2018","journal-title":"Int J Dermatol"},{"issue":"3","key":"R30-20230817","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/dth.12222","article-title":"Off-label use of TNF-alpha inhibitors in a dermatological university department: retrospective evaluation of 118 patients","volume":"28","author":"Sand","year":"2015","journal-title":"Dermatol Ther"},{"issue":"4","key":"R31-20230817","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jaad.2006.07.027","article-title":"Infliximab for severe hidradenitis suppurativa: transient clinical efficacy in 7 consecutive patients","volume":"56","author":"Fardet","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"R32-20230817","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/ajd.12136","article-title":"Moderate to severe hidradenitis suppurativa treated with biological therapies","volume":"55","author":"Chinniah","year":"2014","journal-title":"Australas J Dermatol"},{"issue":"3","key":"R33-20230817","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bjd.14199","article-title":"Antitumour necrosis factor-\u03b1 therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013","volume":"174","author":"Sbidian","year":"2016","journal-title":"Br J Dermatol"},{"issue":"2","key":"R34-20230817","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1365-2133.2007.08332.x","article-title":"Long-term efficacy of a single course of infliximab in hidradenitis suppurativa","volume":"158","author":"Mekkes","year":"2008","journal-title":"Br J Dermatol"},{"issue":"6","key":"R35-20230817","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaad.2007.07.032","article-title":"Efalizumab for the treatment of refractory hidradenitis suppurativa","volume":"57","author":"Strober","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"R36-20230817","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1111\/bjd.13186","article-title":"Use of biologics in the treatment of hidradenitis suppurativa: a review of the Henry Ford Hospital experience","volume":"171","author":"Zhang","year":"2014","journal-title":"Br J Dermatol"},{"issue":"5","key":"R37-20230817","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1684\/ejd.2012.1795","article-title":"Efficacy and tolerance of prolonged infliximab treatment of moderate-to-severe forms of hidradenitis suppurativa","volume":"22","author":"Lesage","year":"2012","journal-title":"Eur J Dermatol"},{"issue":"4","key":"R38-20230817","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/bjd.12713","article-title":"Four-weekly infliximab in the treatment of severe hidradenitis suppurativa","volume":"170","author":"Moriarty","year":"2014","journal-title":"Br J Dermatol"},{"issue":"8","key":"R39-20230817","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/ced.12933","article-title":"Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up","volume":"41","author":"Dessinioti","year":"2016","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"R40-20230817","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000228337","article-title":"The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa","volume":"219","author":"van der Zee","year":"2009","journal-title":"Dermatology"},{"issue":"2","key":"R41-20230817","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000228334","article-title":"Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients","volume":"219","author":"Gener","year":"2009","journal-title":"Dermatology"},{"issue":"1","key":"R42-20230817","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/jdv.12127","article-title":"Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients","volume":"28","author":"Bettoli","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"R43-20230817","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa","volume":"222","author":"Join-Lambert","year":"2011","journal-title":"Dermatology"},{"issue":"4","key":"R44-20230817","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/09546630600830588","article-title":"Hidradenitis suppurativa treated with dapsone: a case series of five patients","volume":"17","author":"Kaur","year":"2006","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"R45-20230817","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000329023","article-title":"Dapsone therapy for hidradenitis suppurativa: a series of 24 patients","volume":"222","author":"Yazdanyar","year":"2011","journal-title":"Dermatology"},{"issue":"1","key":"R46-20230817","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","article-title":"Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer","volume":"164","author":"Boer","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"R47-20230817","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/bjd.12884","article-title":"Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients","volume":"171","author":"Matusiak","year":"2014","journal-title":"Br J Dermatol"},{"issue":"2","key":"R48-20230817","first-page":"155","article-title":"Alitretinoin: a useful agent in the treatment of hidradenitis suppurativa, especially in women of child-bearing age","volume":"150","author":"Verdolini","year":"2015","journal-title":"G Ital Dermatol Venereol"},{"issue":"2","key":"R49-20230817","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/09546630510031403","article-title":"Hidradenitis suppurativa treated with finasteride","volume":"16","author":"Joseph","year":"2005","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"R50-20230817","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ajd.12362","article-title":"A case series of 20 women with hidradenitis suppurativa treated with spironolactone","volume":"56","author":"Lee","year":"2015","journal-title":"Australas J Dermatol"},{"issue":"4","key":"R51-20230817","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/bjd.13385","article-title":"Treatment of hidradenitis suppurativa with intralesional photodynamic therapy using a laser diode attached to an optical cable: a promising new approach","volume":"172","author":"Valladares-Narganes","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"R52-20230817","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/DSS.0000000000000264","article-title":"Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study","volume":"41","author":"Mikkelsen","year":"2015","journal-title":"Dermatol Surg"},{"issue":"2","key":"R53-20230817","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1524-4725.2009.01427.x","article-title":"Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization","volume":"36","author":"Hazen","year":"2010","journal-title":"Dermatol Surg"},{"issue":"6","key":"R54-20230817","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1111\/j.1365-2133.2008.08932.x","article-title":"Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser","volume":"159","author":"Madan","year":"2008","journal-title":"Br J Dermatol"},{"issue":"4","key":"R55-20230817","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jaad.2009.07.048","article-title":"Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser","volume":"62","author":"Mahmoud","year":"2010","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"R56-20230817","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/0974-2077.101377","article-title":"Use of lasers for the management of refractory cases of hidradenitis suppurativa and pilonidal sinus","volume":"5","author":"Jain","year":"2012","journal-title":"J Cutan Aesthet Surg"}],"container-title":["JAAPA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000578768.62051.13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T01:12:22Z","timestamp":1692321142000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/01.JAA.0000578768.62051.13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/01.jaa.0000578768.62051.13","relation":{},"ISSN":["1547-1896"],"issn-type":[{"value":"1547-1896","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}